Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 611 citing articles:

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski, Adriaan A. Voors, Stefan D. Anker, et al.
European Heart Journal (2016) Vol. 37, Iss. 27, pp. 2129-2200
Open Access | Times Cited: 19166
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
John J.V. McMurray, Milton Packer, Akshay S. Desai, et al.
New England Journal of Medicine (2014) Vol. 371, Iss. 11, pp. 993-1004
Open Access | Times Cited: 5977
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski, Adriaan A. Voors, Stefan D. Anker, et al.
European Journal of Heart Failure (2016) Vol. 18, Iss. 8, pp. 891-975
Open Access | Times Cited: 5550
Global Public Health Burden of Heart Failure
Gianluigi Savarese, Lars H. Lund
Cardiac failure review (2017) Vol. 03, Iss. 01, pp. 7-7
Open Access | Times Cited: 2337
The Global Health and Economic Burden of Hospitalizations for Heart Failure
Andrew P. Ambrosy, Gregg C. Fonarow, Javed Butler, et al.
Journal of the American College of Cardiology (2014) Vol. 63, Iss. 12, pp. 1123-1133
Closed Access | Times Cited: 1834
Cardiovascular Disease and Diabetes: Policies for Better Health and Quality of Care

OECD health policy studies (2015)
Closed Access | Times Cited: 1595
Epidemiology and one‐year outcomes in patients with chronic heart failure and preserved, mid‐range and reduced ejection fraction: an analysis of the ESC Heart Failure Long‐Term Registry
Ovidiu Chioncel, Mitja Lainščak, Petar Seferović, et al.
European Journal of Heart Failure (2017) Vol. 19, Iss. 12, pp. 1574-1585
Open Access | Times Cited: 760
European Society of Cardiology Heart Failure Long‐Term Registry (ESC‐HF‐LT): 1‐year follow‐up outcomes and differences across regions
María G. Crespo‐Leiro, Stefan D. Anker, Aldo P. Maggioni, et al.
European Journal of Heart Failure (2016) Vol. 18, Iss. 6, pp. 613-625
Open Access | Times Cited: 660
Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long‐Term Registry
Ovidiu Chioncel, Alexandre Mebazaa, Veli‐Pekka Harjola, et al.
European Journal of Heart Failure (2017) Vol. 19, Iss. 10, pp. 1242-1254
Open Access | Times Cited: 448
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski, Adriaan A. Voors, Stefan D. Anker, et al.
Kardiologia Polska (2016) Vol. 74, Iss. 10, pp. 1037-1147
Open Access | Times Cited: 409
Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study
Wouter Ouwerkerk, A.A. Voors, S. D. Anker, et al.
European Heart Journal (2017) Vol. 38, Iss. 24, pp. 1883-1890
Open Access | Times Cited: 362
Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction
Ulrik Sartipy, Ulf Dahlström, Michael Fu, et al.
JACC Heart Failure (2017) Vol. 5, Iss. 8, pp. 565-574
Closed Access | Times Cited: 325
Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study
Rolf Wachter, Michele Senni, Jan Bělohlávek, et al.
European Journal of Heart Failure (2019) Vol. 21, Iss. 8, pp. 998-1007
Open Access | Times Cited: 303
Cardiorenal Syndrome Revisited
Faı̈ez Zannad, Patrick Rossignol
Circulation (2018) Vol. 138, Iss. 9, pp. 929-944
Open Access | Times Cited: 270
Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry
Barak Zafrir, Lars H. Lund, Cécile Laroche, et al.
European Heart Journal (2018) Vol. 39, Iss. 48, pp. 4277-4284
Open Access | Times Cited: 248
Acute heart failure congestion and perfusion status – impact of the clinical classification on in‐hospital and long‐term outcomes; insights from the ESC‐EORP‐HFA Heart Failure Long‐Term Registry
Ovidiu Chioncel, Alexandre Mebazaa, Aldo P. Maggioni, et al.
European Journal of Heart Failure (2019) Vol. 21, Iss. 11, pp. 1338-1352
Open Access | Times Cited: 247
Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology
Giuseppe Rosano, Brenda Moura, Marco Metra, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 6, pp. 872-881
Open Access | Times Cited: 228
Physicians' adherence to guideline‐recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey
Michel Komajda, Stefan D. Anker, Martín Cowie, et al.
European Journal of Heart Failure (2016) Vol. 18, Iss. 5, pp. 514-522
Open Access | Times Cited: 223
Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry
Michel Komajda, Martín Cowie, Luigi Tavazzi, et al.
European Journal of Heart Failure (2017) Vol. 19, Iss. 11, pp. 1414-1423
Open Access | Times Cited: 223
Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double‐blind, randomized comparison of two uptitration regimens
Michele Senni, John J.V. McMurray, Rolf Wachter, et al.
European Journal of Heart Failure (2016) Vol. 18, Iss. 9, pp. 1193-1202
Open Access | Times Cited: 220
Health-Related Quality of Life and Mortality in Heart Failure: The Global Congestive Heart Failure Study of 23 000 Patients From 40 Countries
Isabelle Johansson, Philip Joseph, Kumar Balasubramanian, et al.
Circulation (2021) Vol. 143, Iss. 22, pp. 2129-2142
Open Access | Times Cited: 211
Heart failure with reduced ejection fraction
Michelle Bloom, Barry Greenberg, Tiny Jaarsma, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Closed Access | Times Cited: 191
Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis
Jonatan Barrera‐Chimal, Sophie Girerd, Frédéric Jaisser
Kidney International (2019) Vol. 96, Iss. 2, pp. 302-319
Open Access | Times Cited: 191
The Dapagliflozin And Prevention of Adverse‐outcomes in Heart Failure (DAPA‐HF) trial: baseline characteristics
John J.V. McMurray, David L. DeMets, Silvio E. Inzucchi, et al.
European Journal of Heart Failure (2019) Vol. 21, Iss. 11, pp. 1402-1411
Open Access | Times Cited: 188
Effects of dapagliflozin in DAPA-HF according to background heart failure therapy
Kieran F. Docherty, Pardeep S. Jhund, Silvio E. Inzucchi, et al.
European Heart Journal (2020) Vol. 41, Iss. 25, pp. 2379-2392
Open Access | Times Cited: 171
Page 1 - Next Page

Scroll to top